Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial - Concepedia

Concepedia

Publication | Open Access

Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

DOI Full Paper Access

96

Citations

24

References

2022

Year

Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose, Laurent Servais, Hui Xiong, Edmar Zanoteli, Giovanni Baranello, Claudio Bruno, John Day, Nicolas Deconinck,

The Lancet Neurology

Type 1Firefish Part 2RehabilitationNeurologySpinal Muscular AtrophyMedicineSpinal DisorderOrthopaedic SurgeryNeuromusculoskeletal Disorder

References

	Year	Citations

Page 1

Page 1